These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31959609)

  • 1. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh.
    Zaman K; Dudman S; Stene-Johansen K; Qadri F; Yunus M; Sandbu S; Gurley ES; Overbo J; Julin CH; Dembinski JL; Nahar Q; Rahman A; Bhuiyan TR; Rahman M; Haque W; Khan J; Aziz A; Khanam M; Streatfield PK; Clemens JD
    BMJ Open; 2020 Jan; 10(1):e033702. PubMed ID: 31959609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial.
    Zaman K; Julin CH; Aziz AB; Stene-Johansen K; Yunus M; Qadri F; Gurley ES; Sandbu S; Øverbø J; Dembinski JL; Laake I; Bhuiyan TR; Rahman M; Haque W; Khanam M; Clemens JD; Dudman S
    Lancet Glob Health; 2024 Aug; 12(8):e1288-e1299. PubMed ID: 39030060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial.
    Aziz AB; Dudman S; Julin CH; Ahmmed F; Stene-Johansen K; Sandbu S; Øverbø J; Dembinski JL; Wisløff T; Rana S; Basunia AH; Haque W; Qadri F; Zaman K; Clemens JD
    Lancet Glob Health; 2024 Aug; 12(8):e1300-e1311. PubMed ID: 39030061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.
    Zhu FC; Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Wang H; Yang CL; Jiang HM; Cai JP; Wang YJ; Ai X; Hu YM; Tang Q; Yao X; Yan Q; Xian YL; Wu T; Li YM; Miao J; Ng MH; Shih JW; Xia NS
    Lancet; 2010 Sep; 376(9744):895-902. PubMed ID: 20728932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of new hepatitis E vaccines.
    Cao Y; Bing Z; Guan S; Zhang Z; Wang X
    Hum Vaccin Immunother; 2018; 14(9):2254-2262. PubMed ID: 29708836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E virus: Current epidemiology and vaccine.
    Wu X; Chen P; Lin H; Hao X; Liang Z
    Hum Vaccin Immunother; 2016 Oct; 12(10):2603-2610. PubMed ID: 27184971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial.
    Øverbø J; Aziz A; Zaman K; Clemens J; Halle Julin C; Qadri F; Stene-Johansen K; Biswas R; Islam S; Rahman Bhuiyan T; Haque W; Sandbu S; Elahee ME; Ali M; Dembinski JL; Dudman S
    Vaccine; 2023 Jan; 41(5):1059-1066. PubMed ID: 36599736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years.
    Yu XY; Chen ZP; Wang SY; Pan HR; Wang ZF; Zhang QF; Shen LZ; Zheng XP; Yan CF; Lu M; Chen B; Zheng Y; Zhang J; Lv HK; Huang SJ
    Vaccine; 2019 Jul; 37(32):4581-4586. PubMed ID: 31262585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E should be a global public health priority: recommendations for improving surveillance and prevention.
    Kirkwood CD; Dobscha KR; Steele AD
    Expert Rev Vaccines; 2020 Dec; 19(12):1129-1140. PubMed ID: 33441054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy.
    Sridhar S; Situ J; Cai JP; Yip CC; Wu S; Zhang AJ; Wen L; Chew NF; Chan WM; Poon RW; Chan JF; Tsang DN; Chen H; Xia NS; Yuen KY
    J Hepatol; 2021 Jun; 74(6):1315-1324. PubMed ID: 33845058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E, a vaccine-preventable cause of maternal deaths.
    Labrique AB; Sikder SS; Krain LJ; West KP; Christian P; Rashid M; Nelson KE
    Emerg Infect Dis; 2012 Sep; 18(9):1401-4. PubMed ID: 22931753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination.
    Su YY; Huang SJ; Guo M; Zhao J; Yu H; He WG; Jiang HM; Wang YJ; Zhang XF; Cai JP; Yang CL; Wang ZZ; Zhu FC; Wu T; Zhang J; Xia NS
    Clin Microbiol Infect; 2017 May; 23(5):336.e1-336.e4. PubMed ID: 27836809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of hepatitis E in urban Bangladesh resulting in maternal and perinatal mortality.
    Gurley ES; Hossain MJ; Paul RC; Sazzad HM; Islam MS; Parveen S; Faruque LI; Husain M; Ara K; Jahan Y; Rahman M; Luby SP
    Clin Infect Dis; 2014 Sep; 59(5):658-65. PubMed ID: 24855146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HEV infection as an aetiologic factor for acute hepatitis: experience from a tertiary hospital in Bangladesh.
    Mamun-Al-Mahtab ; Rahman S; Khan M; Karim F
    J Health Popul Nutr; 2009 Feb; 27(1):14-9. PubMed ID: 19248644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults.
    Wu T; Huang SJ; Zhu FC; Zhang XF; Ai X; Yan Q; Wang ZZ; Yang CL; Jiang HM; Liu XH; Guo M; Du HL; Ng MH; Zhang J; Xia NS
    Hum Vaccin Immunother; 2013 Nov; 9(11):2474-9. PubMed ID: 23887167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis E virus infection in pregnant women, Argentina.
    Tissera G; Lardizabal MC; Torres SB; Fantilli AC; Martínez Wassaf MG; Venezuela F; Capra R; Balderramo DC; Travella C; Ré VE; Pisano MB
    BMC Infect Dis; 2020 May; 20(1):368. PubMed ID: 32448132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive and pre-emptive vaccination strategies to control hepatitis E infection in emergency and refugee settings: A modelling study.
    Cooper BS; White LJ; Siddiqui R
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006807. PubMed ID: 30252843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis E virus among pregnant women and control subjects in China.
    Cong W; Sui JC; Zhang XY; Qian AD; Chen J; Zhu XQ
    J Med Virol; 2015 Mar; 87(3):446-50. PubMed ID: 25164987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E-related adverse pregnancy outcomes and their prevention by hepatitis E vaccine in a rabbit model.
    Li M; Li S; He Q; Liang Z; Wang L; Wang Q; Wang L
    Emerg Microbes Infect; 2019; 8(1):1066-1075. PubMed ID: 31339458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis E as a cause of adult hospitalization in Bangladesh: Results from an acute jaundice surveillance study in six tertiary hospitals, 2014-2017.
    Paul RC; Nazneen A; Banik KC; Sumon SA; Paul KK; Akram A; Uzzaman MS; Iqbal T; Tejada-Strop A; Kamili S; Luby SP; Gidding HF; Hayen A; Gurley ES
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007586. PubMed ID: 31961861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.